CS
CSL Seqirus at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
CSL Seqirus brings 4 presentations to IDWeek 2026 in Washington. Its program centres on influenza vaccines and their knock-on effect on antibiotic use. It compares adjuvanted and high-dose flu vaccines, models wider cell-based vaccination of US children, and looks at how better vaccines could cut flu-related antibiotic prescribing.
| Organization | IDWeek 2026 Attendance |
|---|---|
CS CSL Seqirus | |
Influenza vaccine business of CSL, making seasonal and pandemic flu vaccines. | Poster Fri Oct 23 12:15pm–1:30pm Influenza-Associated Antibiotic Prescribing and the Potential Impact of More Effective Vaccines on Antimicrobial Stewardship Poster Sat Oct 24 12:15pm–1:30pm Clinical and Economic Effects of Expanded Pediatric Influenza Immunization Using Cell‑Based Vaccines in the United States Poster Sat Oct 24 12:15pm–1:30pm Meta-analysis of Relative Vaccine Effectiveness of Adjuvanted (aTIV/aQIV) vs High-dose Influenza Vaccines (HD-TIV/HD-QIV) for Prevention of Influenza Talk Sat Oct 24 12:40pm–12:45pm Influenza-Associated Antibiotic Prescribing and the Potential Impact of More Effective Vaccines on Antimicrobial Stewardship Antimicrobials, resistance and stewardshipVaccines |
Instantly find 20 buyers from CSL Seqirus
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction